|
1
|
GBD 2015 Disease and Injury Incidence and
Prevalence Collaborators, : Global, regional, and national
incidence, prevalence, and years lived with disability for 310
diseases and injuries, 1990–2015: A systematic analysis for the
Global Burden of Disease Study 2015. Lancet. 388:1545–1602. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
GBD 2015 Mortality and Causes of Death
Collaborators, : Global, regional, and national life expectancy,
all-cause mortality, and cause-specific mortality for 249 causes of
death, 1980–2015: A systematic analysis for the Global Burden of
Disease Study 2015. Lancet. 388:1459–1544. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Enkhtaivan G, Kim DH and Pandurangan M:
Cytotoxic effect of TDZ on human cervical cancer cells. J Photochem
Photobiol B. 173:493–498. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sud A, Kinnersley B and Houlston RS:
Genome-wide association studies of cancer: Current insights and
future perspectives. Nat Rev Cancer. 17:692–704. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herati AS, Kohn TP, Butler PR and
Lipshultz LI: Effects of testosterone on benign and malignant
conditions of the prostate. Curr Sex Health Rep. 9:65–73. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Edgren G, Liang L, Adami HO and Chang ET:
Enigmatic sex disparities in cancer incidence. Eur J Epidemiol.
27:187–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Micalizzi DS, Maheswaran S and Haber DA: A
conduit to metastasis: Circulating tumor cell biology. Genes Dev.
31:1827–1840. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pascual G, Avgustinova A, Mejetta S,
Martin M, Castellanos A, Attolini CS, Berenguer A, Prats N, Toll A,
Hueto JA, et al: Targeting metastasis-initiating cells through the
fatty acid receptor CD36. Nature. 541:41–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Blee AM and Huang H: Fat lure: Adipocytes
attract cancer cells out of the prostate. Translational Cancer Res.
5 Suppl 1:S123–S125. 2016. View Article : Google Scholar
|
|
10
|
Rojas KE, Matthews N, Raker C, Clark MA,
Onstad M, Stuckey A and Gass J: Body mass index (BMI),
postoperative appearance satisfaction, and sexual function in
breast cancer survivorship. J Cancer Surviv. 12:127–133. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Amadou A, Ferrari P, Muwonge R, Moskal A,
Biessy C, Romieu I and Hainaut P: Overweight, obesity and risk of
premenopausal breast cancer according to ethnicity: A systematic
review and dose-response meta-analysis. Obes Rev. 14:665–678. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Finucane MM, Stevens GA, Cowan MJ, Danaei
G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN,
et al: National, regional, and global trends in body-mass index
since 1980: Systematic analysis of health examination surveys and
epidemiological studies with 960 country-years and 9.1 million
participants. Lancet. 377:557–567. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rafee S, Flavin A and O'Reilly S: Body
fatness and cancer. N Engl J Med. 375:20082016.PubMed/NCBI
|
|
14
|
Montazeri A: Quality of life data as
prognostic indicators of survival in cancer patients: An overview
of the literature from 1982 to 2008. Health Qual Life Outcomes.
7:1022009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moghimi-Dehkordi B and Safaee A: An
overview of colorectal cancer survival rates and prognosis in Asia.
World J Gastrointest Oncol. 4:71–75. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang Y, Qiao G, Xu E, Xuan Y, Liao M and
Yin G: Biomarkers for early diagnosis, prognosis, prediction, and
recurrence monitoring of non-small cell lung cancer. Onco Targets
Ther. 10:4527–4534. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gesthalter YB, Vick J, Steiling K and
Spira A: Translating the transcriptome into tools for the early
detection and prevention of lung cancer. Thorax. 70:476–481. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li M, Wang MM, Guo XW, Wu CY, Li DR, Zhang
X and Zhang PT: Different survival benefits of Chinese medicine for
pancreatic cancer: How to choose? Chin J Integr Med. 24:178–184.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wills B, Cardona AF, Rojas L, Ruiz-Patino
A, Arrieta O, Reguart N, Carranza H, Vargas C, Otero J, Corrales L,
et al: Survival outcomes according to TIMP1 and EGFR expression in
heavily treated patients with advanced non-small cell lung cancer
who received biweekly irinotecan plus bevacizumab. Anticancer Res.
37:6429–6436. 2017.PubMed/NCBI
|
|
20
|
Mercier J and Voutsadakis IA: A Systematic
review and Meta-analysis of retrospective series of regorafenib for
treatment of metastatic colorectal cancer. Anticancer Res.
37:5925–5934. 2017.PubMed/NCBI
|
|
21
|
Sineshaw HM, Jemal A, Thomas CJ and Mitin
T: Changes in treatment patterns for patients with locally advanced
rectal cancer in the United States over the past decade: An
analysis from the National Cancer Data Base. Cancer. 122:1996–2003.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shiani A, Narayanan S, Pena L and Friedman
M: The role of diagnosis and treatment of underlying liver disease
for the prognosis of primary liver cancer. Cancer Control. 24:2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chennubhotla C, Clarke LP, Fedorov A,
Foran D, Harris G, Helton E, Nordstrom R, Prior F, Rubin D, Saltz
JH, et al: An assessment of imaging informatics for precision
medicine in cancer. Yearb Med Inform. 26:110–119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brunner M, Olschewski M, Geibel A, Bode C
and Zehender M: Long-term survival after pacemaker implantation.
Prognostic importance of gender and baseline patient
characteristics. Eur Heart J. 25:88–95. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Burney IA and Lakhtakia R: Precision
medicine: Where have we reached and where are we headed? Sultan
Qaboos Univ Med J. 17:e255–e258. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yavas O, Hayran M and Ozisik Y: Factors
affecting survival in breast cancer patients following bone
metastasis. Tumori. 93:580–586. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chok KS and Law WL: Prognostic factors
affecting survival and recurrence of patients with pT1 and pT2
colorectal cancer. World J Surg. 31:1485–1490. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Labastida R, Dexeus S, Fábregas R,
Tresserra F and Fernández A: Endometrial cancer: Factors affecting
survival. Eur J Gynaecol Oncol. 24:381–383. 2003.PubMed/NCBI
|
|
30
|
Kojima F, Yamamoto K, Matsuoka K, Ueda M,
Hamada H, Imanishi N and Miyamoto Y: Factors affecting survival
after lobectomy with pulmonary artery resection for primary lung
cancer. Eur J Cardiothorac Surg. 40:e13–e20. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
de Magalhães JP: How ageing processes
influence cancer. Nat Rev Cancer. 13:357–365. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
May M: Statistics: Attacking an epidemic.
Nature. 509 Suppl:S50–S51. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eveno C, Parc Y, Laurent A, Ducreux M and
Pocard M: Body-mass index, cancer, and implications for screening.
Lancet Oncol. 16:e102–e103. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Warren JL, Harlan LC, Trimble EL, Stevens
J, Grimes M and Cronin KA: Trends in the receipt of guideline care
and survival for women with ovarian cancer: A population-based
study. Gynecol Oncol. 145:486–492. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jensen JS, Jensen DH, Grønhøj C, Karnov
KKS, Nørregaard C, Agander TK, Specht L and von Buchwald C:
Incidence and survival of oropharyngeal cancer in Denmark: A
nation-wide, population-based study from 1980 to 2014. Acta Oncol.
57:269–275. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Welch HG, Schwartz LM and Woloshin S: Are
increasing 5-year survival rates evidence of success against
cancer? JAMA. 283:2975–2978. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hallahan C: Data Analysis using SAS.
Sociological Methods Res. 23:373–391. 1995. View Article : Google Scholar
|
|
38
|
Xu M, Fralick D, Zheng JZ, Wang B, Tu XM
and Feng C: The differences and similarities between Two-sample
T-Test and Paired T-Test. Shanghai Arch Psychiatry. 29:184–188.
2017.PubMed/NCBI
|
|
39
|
Kim HY: Statistical notes for clinical
researchers: Chi-squared test and Fisher's exact test. Restor Dent
Endod. 42:152–155. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cuff J and Higgins JP: Statistical
analysis of surgical pathology data using the R program. Adv Anat
Pathol. 19:131–139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schwartz L, Supuran CT and Alfarouk KO:
The Warburg effect and the hallmarks of cancer. Anticancer Agents
Med Chem. 17:164–170. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hofseth LJ and Wargovich MJ: Inflammation,
cancer, and targets of ginseng. J Nutr. 137 Suppl 1:183S–185S.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cao B, Bray F, Beltran-Sanchez H, Ginsburg
O, Soneji S and Soerjomataram I: Benchmarking life expectancy and
cancer mortality: Global comparison with cardiovascular disease
1981–2010. BMJ. 357:j27652017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
May M, Bastian PJ, Brookman-May S,
Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L,
Herrmann E, et al: Gender-specific differences in cancer-specific
survival after radical cystectomy for patients with urothelial
carcinoma of the urinary bladder in pathologic tumor stage T4a.
Urol Oncol. 31:1141–1147. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Corbett JB and Mori M: Gender-specific
cancers, Gender-specific reporters? Twenty-Four years of network TV
coverage. Sci Communication. 20:395–408. 1999. View Article : Google Scholar
|
|
46
|
Koyama A, Matsuoka H, Ohtake Y, Makimura
C, Sakai K, Sakamoto R and Murata M: Gender differences in
cancer-related distress in Japan: A retrospective observation
study. Biopsychosoc Med. 10:102016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Key T, Appleby P, Barnes I and Reeves G;
Endogenous Hormones and Breast Cancer Collaborative Group, :
Endogenous sex hormones and breast cancer in postmenopausal women:
Reanalysis of nine prospective studies. J Natl Cancer Inst.
94:606–616. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hall SA, Araujo AB, Kupelian V, Maserejian
NN and Travison TG: Testosterone and breast cancer. J Sex Med.
7:1035–1037. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Naugler WE, Sakurai T, Kim S, Maeda S, Kim
K, Elsharkawy AM and Karin M: Gender disparity in liver cancer due
to sex differences in MyD88-dependent IL-6 production. Science.
317:121–124. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
NCD Risk Factor Collaboration (NCD-RisC),
: Trends in adult body-mass index in 200 countries from 1975 to
2014: A pooled analysis of 1698 population-based measurement
studies with 19.2 million participants. Lancet. 387:1377–1396.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bosy-Westphal A, Reinecke U, Schlörke T,
Illner K, Kutzner D, Heller M and Müller MJ: Effect of organ and
tissue masses on resting energy expenditure in underweight, normal
weight and obese adults. Int J Obes Relat Metab Disord. 28:72–79.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Dirat B, Bochet L, Dabek M, Daviaud D,
Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S,
et al: Cancer-associated adipocytes exhibit an activated phenotype
and contribute to breast cancer invasion. Cancer Res. 71:2455–2465.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Omabe M, Ezeani M and Omabe KN: Lipid
metabolism and cancer progression: The missing target in metastatic
cancer treatment. J Appl Biomed. 13:47–59. 2015. View Article : Google Scholar
|
|
54
|
Freitas R Jr, Freitas NM, Curado MP,
Martins E, Silva CM, Rahal RM and Queiroz GS: Incidence trend for
breast cancer among young women in Goiania, Brazil. Sao Paulo Med
J. 128:81–84. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wiener HG, Klinkhamer P, Schenck U, Arbyn
M, Bulten J, Bergeron C and Herbert A: European guidelines for
quality assurance in cervical cancer screening: Recommendations for
cytology laboratories. Cytopathology. 18:67–78. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Arnautovic A, Billups C, Broniscer A,
Gajjar A, Boop F and Qaddoumi I: Delayed diagnosis of childhood
low-grade glioma: Causes, consequences, and potential solutions.
Child Nerv Syst. 31:1067–1077. 2015. View Article : Google Scholar
|
|
57
|
Clegg LX, Li FP, Hankey BF, Chu K and
Edwards BK: Cancer survival among US whites and minorities: A SEER
(Surveillance, Epidemiology, and End Results) Program
population-based study. Arch Intern Med. 162:1985–1993. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Weinstock C, Bigenwald R, Hochman T, Sun
P, Narod SA and Warner E: Outcomes of surveillance for
contralateral breast cancer in patients less than age 60 at the
time of initial diagnosis. Curr Oncol. 19:e160–e164. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Boyd AL, Reid JC, Salci KR, Aslostovar L,
Benoit YD, Shapovalova Z, Nakanishi M, Porras DP, Almakadi M,
Campbell CJV, et al: Acute myeloid leukaemia disrupts endogenous
myelo-erythropoiesis by compromising the adipocyte bone marrow
niche. Nat Cell Biol. 19:1336–1347. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Casartelli G, Dorcaratto A, Ravetti JL,
Sola S, Vitali A, Merlo DF and Frosina G: Survival of high grade
glioma patients depends on their age at diagnosis. Cancer Biol
Ther. 8:1719–1721. 2009. View Article : Google Scholar : PubMed/NCBI
|
